Search for Clinical Trial Results

Sponsored By

Leishmaniasis - 70 Studies Found

Status Study
Completed Study Name: A Community Trial for Visceral Leishmaniasis (VL)
Condition: Visceral Leishmaniasis
Date: 2010-02-14
Interventions:
  • Drug: Albendazole, Iron, Zinc and Vitamin A

Completed Study Name: Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
Condition: Primary Visceral Leishmaniasis
Date: 2010-02-10
Interventions:
  • Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate

Completed Study Name: Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
Condition:
  • Visceral Leishmaniasis
  • Kala Azar Date: 2006-04-25
    Interventions: Device: Long Lasting Impregnated Nets (LLIN) Distribution of LLIN in selected clusters
Completed Study Name: Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Date: 2005-09-13
Interventions:
  • Drug: Paromomycin sulfate
  • Drug: Amphoteric
Completed Study Name: Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
Condition: Visceral Leishmaniasis
Date: 2015-04-20
Interventions: Drug: Miltefosine
Not yet recruiting Study Name: Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
Condition: Visceral Leishmaniasis
Date: 2017-04-21
Interventions:
  • Drug: Miltefosine Miltefosine

Completed Study Name: Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Date: 2008-06-11
Interventions:
  • Drug: Amphotericin B Deoxycholate

Completed Study Name: A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
Condition: Post-kala-azar Dermal Leishmaniasis
Date: 2013-10-23
Interventions: Drug: Mitefosine Tablet Miltefosine 100 mg in two devided doses for 12 weeks
Completed Study Name: Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Date: 2025-08-10
Interventions: Sessions will be held once weekly for a maximum of 6 weeks
COMPLETED Study Name: Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
Condition: Leishmaniasis
Date: 2025-08-10
<<< Previous